Flowsense, an Israeli company which develops medical devices for urine monitoring, has announced that it has signed a letter of intent with a foreign healthcare company. The unnamed company is interested in buying it for $7-10 million, on a non-cash basis and without debts.
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts

AI Made In Israel Helping Europeans Conceive Via IVF
June 08, 2023
Facebook comments